Our Blog
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore magna sit voluptatem aliqua.
HealthBanks’ Subsidiary ImmuneCyte Acquires Boyalife’s Cellular Therapy Division to Expand Clinical Development for Cell and Gene Therapies
IRVINE, Calif., March 08, 2021 – HealthBanks Biotech (USA), Inc. (“HealthBanks” or the “Company”), a premium cell banking network, today announced that through its subsidiary, ImmuneCyte Inc. (“ImmuneCyte”), the Company has executed an acquisition agreement with...
ThermoGenesis Unveils Comprehensive Suite of Products and Services to Fight the Global COVID-19 Pandemic
RANCHO CORDOVA, Calif., Sept 2, 2020 -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, along with its joint venture, ImmuneCyte, Inc. today announced plans to roll out a...
ThermoGenesis and ImmuneCyte Joint Venture Developing Several Convalescent Plasma and Antibody Therapeutic Approaches Against COVID-19, Featured on FOX40 and Other Local News Outlets
RANCHO CORDOVA, Calif., April 24, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was featured on multiple new outlets, including a Fox40...
Classificação dos melhores casinos online para portugueses pela Znaki.FM
Casino online – estes são análogos virtuais de Casinos regulares que permitem aos usuários jogar jogos de azar pela Internet. Os casinos online originais começaram em meados da década de 1990 e desde então sofreram alterações significativas, tornando-se mais...
COVID-19 Antibody Test Kit Ready for Distribution
COVID-19 Test Ready For Distribution -- Irvine, Calif., April 16, 2020 -- ImmuneCyte, announced today that on Wednesday April 15th, ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a major shareholder of ImmuneCyte, a market leader in automated cell processing tools and...
Fight Against COVID-19 Using Fully Human Polyclonal and Monoclonal Antibody Therapeutics
IRVINE, Calif., April 13, 2020 – ImmuneCyte Life Sciences, Inc., announced today that the Company has completed the acquisition of worldwide intellectual property for developing fully human antibody therapeutics for COVID-19. The acquired intellectual property...
ImmuneCyte and ThermoGenesis’ Rapid COVID-19 Testing Kit Featured on Local CBS News Titled: “Different Kind of Coronavirus Test”
RANCHO CORDOVA, Calif., April 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was featured on a CBS 13 news segment titled, “Different...
ThermoGenesis, a Major Shareholder of Immunecyte, Announces that it has Notified the FDA of its Intent to Distribute the Company’s Rapid COVID-19 Point-of-Care Test Kit
RANCHO CORDOVA, Calif., March 31, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a major shareholder of Immunecyte, a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it has notified the U.S....
Recent Update on Coronavirus (COVID-19) Pandemic
RANCHO CORDOVA, Calif., March 24, 2020 — The current global pandemic of the coronavirus (COVID-19) has now affected more than 180 countries and regions, including over 40,000 cases in the United States alone. The disease has spread rapidly, leading to a tremendous...
Leave A Message
©2020 All rights reserved. ImmuneCyte, Inc.
A Healthbanks Biotech Company
